Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 48

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.

miRNA-93-5p in exosomes derived from M2 macrophages improves lipopolysaccharide-induced podocyte apoptosis by targeting Toll-like receptor 4

Wang, Zhu, Sun, Wansen, Li, Ruiping, Liu, Yan·2022·Bioengineered

Abstract

Diabetic nephropathy (DN) is a common complication of diabetes mellitus which can result in renal failure and severely affect public health. Several studies have revealed the important role of podocyte injury in DN progression. Although, the involvement of exosomes derived from M2 macrophages has been reported in podocyte injury, the underlying molecular mechanism of M2 macrophage-secreted exosomes has not been fully elucidated. Our study suggests that M2 macrophages mitigate lipopolysaccharide (LPS)-induced injury of podocytes via exosomes. Moreover, we observed that miR-93-5p expression was markedly upregulated in exosomes from M2 macrophages. Inhibition of miR-93-5p derived from M2 macrophage exosomes resulted in apoptosis of LPS-treated podocytes. Additionally, TLR4 showed the potential to bind to miR-93-5p. Subsequently, we validated that TLR4 is a downstream target of miR-93-5p. Further findings indicated that silencing of TLR4 reversed the renoprotective effects of miR-93-5p-containing M2 macrophage exosomes on LPS-induced podocyte injury. In summary, our study demonstrated that M2 macrophage-secreted exosomes attenuated LPS-induced podocyte apoptosis by regulating the miR-93-5p/TLR4 axis, which provides a new perspective for the treatment of patients with DN.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/21655979.2021.2023794

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. M2 macrophages inhibit apoptosis of LPS-induced podocytes through secreting exosomes. (a) Western blot analysis of CD68, CD206 and CD163 expression levels. (b) Flow cytometric analysis was carried out to ascertain the mode of action of macrophages in podocyte injury. (c) After LPS, M0, M1, M2 and GW4869 treatments, the expression of Bax, Bax, and cleaved caspase 3 in podocytes was detected by Western blotting. LPS, lipopolysaccharide; M0, M1, M2, different subtypes macrophage. **P < 0.01.
Figure 1. M2 macrophages inhibit apoptosis of LPS-induced podocytes through secreting exosomes. (a) Western blot analysis of CD68, CD206 and CD163 expression levels. (b) Flow cytometric analysis was carried out to ascertain the mode of action of macrophages in podocyte injury. (c) After LPS, M0, M1, M2 and GW4869 treatments, the expression of Bax, Bax, and cleaved caspase 3 in podocytes was detected by Western blotting. LPS, lipopolysaccharide; M0, M1, M2, different subtypes macrophage. **P < 0.01.CC BY · PubMed Central
Figure 2. M2 macrophage-derived exosomes alleviate the injury of LPS-treated podocytes. (a) Exosomes isolated from different macrophage subtypes were identified with transmission electron microscopy (TEM). (b) Western blot analysis of CD9, CD63 and TSG101 levels in macrophage-derived exosomes. (c) Apoptosis of podocytes determined by flow cytometric analysis. (d) Western blotting was performed to detect the expression of Bcl-2, Bax and cleaved caspase 3 in podocytes. LPS, lipopolysaccharide; Bcl-2, B-cell lymphoma-2; Bax, BCL2-Associated X; **P < 0.01 vs CON, ##P < 0.01.
Figure 2. M2 macrophage-derived exosomes alleviate the injury of LPS-treated podocytes. (a) Exosomes isolated from different macrophage subtypes were identified with transmission electron microscopy (TEM). (b) Western blot analysis of CD9, CD63 and TSG101 levels in macrophage-derived exosomes. (c) Apoptosis of podocytes determined by flow cytometric analysis. (d) Western blotting was performed to detect the expression of Bcl-2, Bax and cleaved caspase 3 in podocytes. LPS, lipopolysaccharide; Bcl-2, B-cell lymphoma-2; Bax, BCL2-Associated X; **P < 0.01 vs CON, ##P < 0.01.CC BY · PubMed Central
Figure 3. miR-93-5p is highly expressed in exosomes secreted by M2 macrophages. (a) Expression of miR-93-5p in exosomes from different macrophage subtypes was measured by RT-qPCR. (b) Transfection efficiency of miR-93-5p inhibitor was verified in macrophages treated with and without LPS by RT-qPCR analysis. (c) RT-qPCR analysis of miR-93-5p expression in exosomes transfected with miR-93-5p inhibitors. (d) Uptake of exosomal miR-93-5p into podocytes was visualized with a fluorescent microscope. (e) Following LPS, M2-Exo and miR-93-5p inhibitor treatments, miR-93-5p expression in podocytes was examined with RT-qPCR assay. LPS, lipopolysaccharide; M2, macrophage; Exo, exosomes **P < 0.01 vs CON, ##P < 0.01.
Figure 3. miR-93-5p is highly expressed in exosomes secreted by M2 macrophages. (a) Expression of miR-93-5p in exosomes from different macrophage subtypes was measured by RT-qPCR. (b) Transfection efficiency of miR-93-5p inhibitor was verified in macrophages treated with and without LPS by RT-qPCR analysis. (c) RT-qPCR analysis of miR-93-5p expression in exosomes transfected with miR-93-5p inhibitors. (d) Uptake of exosomal miR-93-5p into podocytes was visualized with a fluorescent microscope. (e) Following LPS, M2-Exo and miR-93-5p inhibitor treatments, miR-93-5p expression in podocytes was examined with RT-qPCR assay. LPS, lipopolysaccharide; M2, macrophage; Exo, exosomes **P < 0.01 vs CON, ##P < 0.01.CC BY · PubMed Central
Figure 4. Suppression of miR-93-5p in M2 macrophage-derived exosomes facilitates LPS-induced podocyte apoptosis. (a) Apoptosis of podocytes in different groups was evaluated by flow cytometric analysis. (b) Western blotting was performed to detect the expression of Bcl-2, Bax, and cleaved caspase 3 in podocytes after LPS, M2-Exo and miR-93-5p inhibitor treatments. (c) Quantification of Bcl-2, Bax, and cleaved caspase 3 protein levels in podocytes from different groups. LPS, lipopolysaccharide; Bcl-2, B-cell lymphoma-2; Bax, BCL2-Associated X; **P < 0.01.
Figure 4. Suppression of miR-93-5p in M2 macrophage-derived exosomes facilitates LPS-induced podocyte apoptosis. (a) Apoptosis of podocytes in different groups was evaluated by flow cytometric analysis. (b) Western blotting was performed to detect the expression of Bcl-2, Bax, and cleaved caspase 3 in podocytes after LPS, M2-Exo and miR-93-5p inhibitor treatments. (c) Quantification of Bcl-2, Bax, and cleaved caspase 3 protein levels in podocytes from different groups. LPS, lipopolysaccharide; Bcl-2, B-cell lymphoma-2; Bax, BCL2-Associated X; **P < 0.01.CC BY · PubMed Central
Figure 5. TLR4 serves as a target of miR-93-5p. (a) The predicted binding sites between miR-93-5p and TLR4. (b) Dual-luciferase reporter assay was conducted to confirm the relationship between miR-93-5p and TLR4. (c) RT-qPCR analysis of TLR4 expression in M2 macrophages transfected with corresponding oligonucleotides. (d) Western blot analysis of TLR4 protein level in M2 macrophages from different groups. (e) TLR4 expression in macrophage-derived exosomes was detected by RT-qPCR assay. (f-g) RT-qPCR and Western blot analyses of TLR4 level in podocytes treated with exosomes from transfected M2 macrophages. TLR4, Toll-like receptor 4; **P < 0.01.
Figure 5. TLR4 serves as a target of miR-93-5p. (a) The predicted binding sites between miR-93-5p and TLR4. (b) Dual-luciferase reporter assay was conducted to confirm the relationship between miR-93-5p and TLR4. (c) RT-qPCR analysis of TLR4 expression in M2 macrophages transfected with corresponding oligonucleotides. (d) Western blot analysis of TLR4 protein level in M2 macrophages from different groups. (e) TLR4 expression in macrophage-derived exosomes was detected by RT-qPCR assay. (f-g) RT-qPCR and Western blot analyses of TLR4 level in podocytes treated with exosomes from transfected M2 macrophages. TLR4, Toll-like receptor 4; **P < 0.01.CC BY · PubMed Central
Figure 6. Knockdown of TLR4 reversed the role of miR-93-5p inhibitor in LPS-induced podocyte. (a) RT-qPCR was performed to measure the expression of TLR4 in podocytes transfected with si-TLR4 or negative control si-NC. (b) RT-qPCR analysis of TLR4 expression in transfected podocytes treated with exosomes from M2 macrophages. (c) Apoptosis of podocytes determined by flow cytometric analysis. (d) Protein levels of Bcl-2, Bax, and cleaved caspase 3 in podocytes following different treatments. **P < 0.01.
Figure 6. Knockdown of TLR4 reversed the role of miR-93-5p inhibitor in LPS-induced podocyte. (a) RT-qPCR was performed to measure the expression of TLR4 in podocytes transfected with si-TLR4 or negative control si-NC. (b) RT-qPCR analysis of TLR4 expression in transfected podocytes treated with exosomes from M2 macrophages. (c) Apoptosis of podocytes determined by flow cytometric analysis. (d) Protein levels of Bcl-2, Bax, and cleaved caspase 3 in podocytes following different treatments. **P < 0.01.CC BY · PubMed Central
Figure 7. Overexpression of TLR4 reversed the role of miR-93-5p mimic in LPS-induced podocyte. (a) RT-qPCR was performed to measure the expression of TLR4 in podocytes transfected with oe-TLR4 or negative control oe-NC. (b) RT-qPCR analysis of TLR4 expression in transfected podocytes treated with exosomes from M2 macrophages. (c) Apoptosis of podocytes determined by flow cytometric analysis. (d) Protein levels of Bcl-2, Bax, and cleaved caspase 3 in podocytes following different treatments. *P< 0.05, **P < 0.01.
Figure 7. Overexpression of TLR4 reversed the role of miR-93-5p mimic in LPS-induced podocyte. (a) RT-qPCR was performed to measure the expression of TLR4 in podocytes transfected with oe-TLR4 or negative control oe-NC. (b) RT-qPCR analysis of TLR4 expression in transfected podocytes treated with exosomes from M2 macrophages. (c) Apoptosis of podocytes determined by flow cytometric analysis. (d) Protein levels of Bcl-2, Bax, and cleaved caspase 3 in podocytes following different treatments. *P< 0.05, **P < 0.01.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 56 references

Cited by

See all 48

Metadata

Authors
Wang, Z., Sun, W., Li, R., & Liu, Y.
Affiliations
The Second Affiliated Hospital of Xi’An Jiaotong University Health Science Center
Venue
Bioengineered
Published
2022-03
Volume
13
Issue
3
Pages
7683-7696
ISSN
  • 2165-5979
  • 2165-5987
Cited by
48
References
56
Language
en
Funders
reported

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: miRNA-93-5p in exosomes derived from M2 macrophages improves lipopolysaccharide-induced podocyte apoptosis by targeting Toll-like receptor 4. https://app.cochat.ai/papers/10.1080/21655979.2021.2023794
The paper
Wang, Z., Sun, W., Li, R., & Liu, Y. (2022). miRNA-93-5p in exosomes derived from M2 macrophages improves lipopolysaccharide-induced podocyte apoptosis by targeting Toll-like receptor 4. Bioengineered. https://doi.org/10.1080/21655979.2021.2023794

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.